BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 32835214)

  • 1. Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.
    Wada K; Wada Y; Ikemura T
    Gene X; 2020 Dec; 5():100038. PubMed ID: 32835214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.
    Wada K; Wada Y; Ikemura T
    Gene; 2020 Dec; 763S():100038. PubMed ID: 34493367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes.
    Iwasaki Y; Abe T; Ikemura T
    BMC Microbiol; 2021 Mar; 21(1):89. PubMed ID: 33757449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directional and reoccurring sequence change in zoonotic RNA virus genomes visualized by time-series word count.
    Wada Y; Wada K; Iwasaki Y; Kanaya S; Ikemura T
    Sci Rep; 2016 Nov; 6():36197. PubMed ID: 27808119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline.
    Kuchinski KS; Jassem AN; Prystajecky NA
    J Clin Virol; 2020 Oct; 131():104581. PubMed ID: 32889496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.
    Laamarti M; Alouane T; Kartti S; Chemao-Elfihri MW; Hakmi M; Essabbar A; Laamarti M; Hlali H; Bendani H; Boumajdi N; Benhrif O; Allam L; El Hafidi N; El Jaoudi R; Allali I; Marchoudi N; Fekkak J; Benrahma H; Nejjari C; Amzazi S; Belyamani L; Ibrahimi A
    PLoS One; 2020; 15(11):e0240345. PubMed ID: 33170902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-series oligonucleotide count to assign antiviral siRNAs with long utility fit in the big data era.
    Wada K; Wada Y; Iwasaki Y; Ikemura T
    Gene Ther; 2017 Oct; 24(10):668-673. PubMed ID: 28905886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
    Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
    PLoS One; 2020; 15(10):e0237689. PubMed ID: 33006981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin and underlying driving forces of the SARS-CoV-2 outbreak.
    Chaw SM; Tai JH; Chen SL; Hsieh CH; Chang SY; Yeh SH; Yang WS; Chen PJ; Wang HY
    J Biomed Sci; 2020 Jun; 27(1):73. PubMed ID: 32507105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
    Arisan ED; Dart A; Grant GH; Arisan S; Cuhadaroglu S; Lange S; Uysal-Onganer P
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32512929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the "Confined Virus"?
    Alouane T; Laamarti M; Essabbar A; Hakmi M; Bouricha EM; Chemao-Elfihri MW; Kartti S; Boumajdi N; Bendani H; Laamarti R; Ghrifi F; Allam L; Aanniz T; Ouadghiri M; El Hafidi N; El Jaoudi R; Benrahma H; Attar JE; Mentag R; Sbabou L; Nejjari C; Amzazi S; Belyamani L; Ibrahimi A
    Pathogens; 2020 Oct; 9(10):. PubMed ID: 33050463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.
    Xiao M; Liu X; Ji J; Li M; Li J; Yang L; Sun W; Ren P; Yang G; Zhao J; Liang T; Ren H; Chen T; Zhong H; Song W; Wang Y; Deng Z; Zhao Y; Ou Z; Wang D; Cai J; Cheng X; Feng T; Wu H; Gong Y; Yang H; Wang J; Xu X; Zhu S; Chen F; Zhang Y; Chen W; Li Y; Li J
    Genome Med; 2020 Jun; 12(1):57. PubMed ID: 32605661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit.
    Nalla AK; Casto AM; Huang MW; Perchetti GA; Sampoleo R; Shrestha L; Wei Y; Zhu H; Jerome KR; Greninger AL
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32269100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
    Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
    bioRxiv; 2020 Aug; ():. PubMed ID: 32793907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From People to
    McAloose D; Laverack M; Wang L; Killian ML; Caserta LC; Yuan F; Mitchell PK; Queen K; Mauldin MR; Cronk BD; Bartlett SL; Sykes JM; Zec S; Stokol T; Ingerman K; Delaney MA; Fredrickson R; Ivančić M; Jenkins-Moore M; Mozingo K; Franzen K; Bergeson NH; Goodman L; Wang H; Fang Y; Olmstead C; McCann C; Thomas P; Goodrich E; Elvinger F; Smith DC; Tong S; Slavinski S; Calle PP; Terio K; Torchetti MK; Diel DG
    mBio; 2020 Oct; 11(5):. PubMed ID: 33051368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated analysis of variations in SARS-CoV-2 genome.
    Ugurel OM; Ata O; Turgut-Balik D
    Turk J Biol; 2020; 44(3):157-167. PubMed ID: 32595352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
    Glinsky GV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
    Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
    J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.